Petria Thompson, MD, PhD

Resident Physician #radonc @ucsfcancer

[Vanderbilt MSTP @VanderbiltMSTP]

Huge congratulations to our 18 @VanderbiltMSTP Class of 2026 graduates! We are proud of all you have accomplished thus far and look forward to seeing what amazing things you will do in the future!

[Vanderbilt MSTP @VanderbiltMSTP]

Congratulations to our @VanderbiltMSTP Class of 2026 on their #Match2026! We are so proud of all they have accomplished and look forward to what they will accomplish in the future! (1/5)

[BarrowNeurological @BarrowNeuro]

Happy #MatchDay! We're excited to announce and congratulate our incoming residents in #neurosurgery, who will join us this summer at the start of the new academic year.

Michael Covell, @gumedicine
Candace Grisham, @vumedicine
Noah Nawabi, @musc_com
Nicole Perez, @harvardmed

[NEJM @NEJM]

The authors of a new Perspective argue that trainees’ paths to safe, independent practice are variable. Artificial intelligence could help accelerate implementation of competency-based medical education to support individualized development. Read the Perspective by Sanjay V. Desai, MD (@sanjayvdesai), Sal Khan, MBA (@salkhanacademy), and Kimberly Lomis, MD (@KimLomisMD): https://t.co/OCMKuCbsv0

[JAMA @JAMA_current]

In WISDOM, researchers compared risk-based breast cancer screening to standard annual mammography among more than 28 000 US women aged 40 to 74 across all 50 states.

#SABCS25 @SABCSSanAntonio

https://t.co/joDN9TOBdK

[Elisabetta Bonzano MD, PhD @to_be_elizabeth]

📌 ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors

🔗 https://t.co/90zVTShxeO

🔸This is an ESMO-ESTRO initiative on the safety of drug-radiotherapy combinations.
🔹Combining radiotherapy with anti-HER2 monoclonal antibodies is generally safe.
🔸Combining radiotherapy with CDK4/6, PARP, or mTOR inhibitors warrants caution.
🔹Consensus was reached for all 74 clinical scenarios.
@OncoAlert #OncoAlertAF @ESTRO_RT

[ASTRO @ASTRO_org]

Explore ASTRO's Radiation Therapy presentations for Disease-sites

The purpose of these slides is to serve as a resource that any radiation oncologist can use when speaking about the role of radiation therapy in treatment of 8 different disease-sites.

Available to download at https://t.co/PWldHYPErE

[Join Y. Luh, MD (he/him/dude/他) @j_luh]

Caveat from Dr. de Boniface: ""The most important issue from a surgical perspective is that the axillary-node clearance which all patients with positive nodes underwent in the #SUPREMO trial is no longer standard care...the omission of both postmastectomy radiotherapy and axillary-node clearance has thus not been assessed." #bcsm #PMRT #radonc

[Petria Thompson, MD, PhD @Petria_Thompson]

✅ PMRT remains essential for ≥4 nodes, T4, or inflammatory disease.
⚖️ For 1–3 nodes or high-risk pN0 (after ALND + modern therapy) → SUPREMO
SUPREMO shows that some patients can safely avoid radiation without compromising cure.

[Petria Thompson, MD, PhD @Petria_Thompson]

After a mastectomy, who still needs radiation?
The SUPREMO trial (NEJM 2025)re-examined PMRT in the modern systemic therapy era, when recurrence risk is already low. #radonc #onctwitter #medtwitter https://t.co/l69yKmyyh0

[Petria Thompson, MD, PhD @Petria_Thompson]

Caveats/Caution
⚠ Trial opened 2006 → no CDK4/6 or dual HER2 blockade
⚠ Chest-wall RT only (no RNI)
⚠ Upfront surgery only (no NACT)
⚠ Few events → underpowered for ≤2 % absolute benefit

[Lea Alhilali, MD @teachplaygrub]

1/Does PTERYGOPALATINE FOSSA anatomy feel as confusing as its spelling?

Does it seem to have as many openings as letters in its name?

Are you pterrified of the pterygopalatine fossa (PPF)?

Let this thread on PPF anatomy help you out.

[Daniel E Spratt @DrSpratticus]

X-torial: Cleaning up the misinformation about @JoeBiden and #ProstateCancer that I am reading everywhere.

The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA @NCCN PCa guidelines, hold leadership in @NRGonc @theNCI @US_FDA and dedicated my career to help men and their families suffering from PCa

@nytimes @WSJ @FoxNews @CNN @NBCNews @Reuters @ASCO @PCFnews @DeptofDefense

[Vanderbilt MSTP @VanderbiltMSTP]

Congratulations to Atlee Witt (G2), Ansley Kunnath (G4), and Allie Lake (G4) on receiving P.E.O. Scholar Awards! P.E.O. Scholar Award recipients are a select group of women pursuing a doctoral-level degree chosen for their high level of academic achievement.

[UCSF Radiation Oncology @UCSFRadOnc]

New paper in @NatureComms by @UCSF @OlivierMorinSF Evan Porter, Dante Capaldi, Steve Braunstein, et al! "Multi-institutional atlas of brain metastases informs spatial modeling for precision imaging and personalized therapy" @UCSFCancer @NeurosurgUCSF https://t.co/bjStgIRP1O